Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04542408 |
|---|---|
| Brief Title: | Hamburg Edoxaban for Anticoagulation in COVID-19 Study (HERO-19) |
| First Submitted : | September 6, 2020 |
| First Submitted that Met QC Criteria : | September 6, 2020 |
| First Posted : | September 9, 2020 |
| Last Update Submitted that Met QC Criteria : | May 16, 2022 |
| Last Update Posted : | May 17, 2022 |